Erica ULLMAN

Person

Yorktown Heights, NY, US

People

Patents Grantslast 30 patents

Information Patent Grant
Antigen-binding molecules that bind CD38 and/or CD28, and uses thereof
- Patent number 11,905,332
- Issue date Feb 20, 2024
- REGENERON PHARMACEUTICALS, INC.
- David DiLillo
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anti-LAG3 antibodies and uses thereof
- Patent number 11,692,032
- Issue date Jul 4, 2023
- REGENERON PHARMACEUTICALS, INC.
- Erica Ullman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Bispecific anti-PSMA X anti-CD28 antibodies and uses thereof
- Patent number 11,548,947
- Issue date Jan 10, 2023
- REGENERON PHARMACEUTICALS, INC.
- Andrew J. Murphy
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Bispecific anti-MUC16 x anti-CD28 antibodies and uses thereof
- Patent number 11,453,721
- Issue date Sep 27, 2022
- Regeneran Pharmaceuticals, Inc.
- Andrew J. Murphy
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Bispecific anti-CD28 × anti-CD22 antibodies and uses thereof
- Patent number 11,396,544
- Issue date Jul 26, 2022
- REGENERON PHARMACEUTICALS, INC.
- Andrew J. Murphy
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anti-LAG3 antibodies and uses thereof
- Patent number 10,358,495
- Issue date Jul 23, 2019
- REGENERON PHARMACEUTICALS, INC.
- Erica Ullman
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
INTERFERON RECEPTOR ANTAGONISTS AND USES THEREOF
- Publication number 20240376229
- Publication date Nov 14, 2024
- Regeneron Pharmaceuticals, Inc.
- Vidur GARG
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
INDUCED NK CELLS RESPONSIVE TO CD3/TAA BISPECIFIC ANTIBODIES
- Publication number 20240277844
- Publication date Aug 22, 2024
- Regeneron Pharmaceuticals, Inc.
- Nicolin Bloch
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
ANTI-LAG3 ANTIBODIES AND USES THEREOF
- Publication number 20240166740
- Publication date May 23, 2024
- Regeneron Pharmaceuticals, Inc.
- Erica ULLMAN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTIGEN-BINDING MOLECULES THAT BIND CD38 AND/OR CD28, AND USES THEREOF
- Publication number 20240158529
- Publication date May 16, 2024
- Regeneron Pharmaceuticals, Inc.
- David DiLillo
- C07 - ORGANIC CHEMISTRY
Information Patent Application
INTERFERON RECEPTOR AGONISTS AND USES THEREOF
- Publication number 20240101633
- Publication date Mar 28, 2024
- Regeneron Pharmaceuticals, Inc.
- Eva-Maria WEICK
- C07 - ORGANIC CHEMISTRY
Information Patent Application
INTERFERON RECEPTOR AGONISTS AND USES THEREOF
- Publication number 20240067691
- Publication date Feb 29, 2024
- Regeneron Pharmaceuticals, Inc.
- Eva-Maria WEICK
- C07 - ORGANIC CHEMISTRY
Information Patent Application
MULTISPECIFIC ANTIGEN BINDING MOLECULES THAT BIND CD38 AND 4-1BB, A...
- Publication number 20230416396
- Publication date Dec 28, 2023
- Regeneron Pharmaceuticals, Inc.
- Robert Babb
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
INTERLEUKIN-2 PROPROTEINS AND USES THEREOF
- Publication number 20230391844
- Publication date Dec 7, 2023
- Regeneron Pharmaceuticals, Inc.
- Jiaxi WU
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMBINATION OF ANTIBODIES FOR TREATING CANCER WITH REDUCED CYTOKINE...
- Publication number 20230374160
- Publication date Nov 23, 2023
- Regeneron Pharmaceuticals, Inc.
- Aynur Hermann
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Bispecific Anti-PSMA x Anti-CD28 Antibodies and Uses Thereof
- Publication number 20230303696
- Publication date Sep 28, 2023
- Regeneron Pharmaceuticals, Inc.
- Andrew J. Murphy
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Bispecific Anti-MUC16 x Anti-CD28 Antibodies and Uses Thereof
- Publication number 20230279113
- Publication date Sep 7, 2023
- Regeneron Pharmaceuticals, Inc.
- Andrew J. Murphy
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Bispecific Anti-PSMA x Anti-CD28 Antibodies and Uses Thereof
- Publication number 20230272078
- Publication date Aug 31, 2023
- Regeneron Pharmaceuticals, Inc.
- Andrew J. Murphy
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Bispecific Anti-CD28 X Anti-CD22 Antibodies and Uses Thereof
- Publication number 20230174652
- Publication date Jun 8, 2023
- Regeneron Pharmaceuticals, Inc.
- Andrew J. Murphy
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
IL12 RECEPTOR AGONISTS AND METHODS OF USE THEREOF
- Publication number 20230051304
- Publication date Feb 16, 2023
- Regeneron Pharmaceuticals, Inc.
- Aaron CHANG
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
IL2-BASED THERAPEUTICS AND METHODS OF USE THEREOF
- Publication number 20220402989
- Publication date Dec 22, 2022
- Regeneron Pharmaceuticals, Inc.
- Jiaxi Wu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIGEN-BINDING MOLECULES THAT BIND CD38 AND/OR CD28, AND USES THEREOF
- Publication number 20220089766
- Publication date Mar 24, 2022
- Regeneron Pharmaceuticals, Inc.
- David DiLillo
- C07 - ORGANIC CHEMISTRY
Information Patent Application
BISPECIFIC ANTI-CD28 X ANTI-CD22 ANTIBODIES AND USES THEREOF
- Publication number 20200239576
- Publication date Jul 30, 2020
- Regeneron Pharmaceuticals, Inc.
- Andrew J. Murphy
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
BISPECIFIC ANTI-MUC16 X ANTI-CD28 ANTIBODIES AND USES THEREOF
- Publication number 20200199233
- Publication date Jun 25, 2020
- Regeneron Pharmaceuticals, Inc.
- Andrew J. Murphy
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BISPECIFIC ANTI-PSMA X ANTI-CD28 ANTIBODIES AND USES THEREOF
- Publication number 20190389951
- Publication date Dec 26, 2019
- Regeneron Pharmaceuticals, Inc.
- Andrew J. Murphy
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-LAG3 ANTIBODIES AND USES THEREOF
- Publication number 20190284277
- Publication date Sep 19, 2019
- Regeneron Pharmaceuticals, Inc.
- Erica ULLMAN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Anti-LAG3 Antibodies and Uses Thereof
- Publication number 20170101472
- Publication date Apr 13, 2017
- Regeneron Pharmaceuticals, Inc.
- Erica ULLMAN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Erica ULLMAN

Person

Patents Grantslast 30 patents

Antigen-binding molecules that bind CD38 and/or CD28, and uses thereof

Anti-LAG3 antibodies and uses thereof

Bispecific anti-PSMA X anti-CD28 antibodies and uses thereof

Bispecific anti-MUC16 x anti-CD28 antibodies and uses thereof

Bispecific anti-CD28 × anti-CD22 antibodies and uses thereof

Anti-LAG3 antibodies and uses thereof

Patents Applicationslast 30 patents

INTERFERON RECEPTOR ANTAGONISTS AND USES THEREOF

INDUCED NK CELLS RESPONSIVE TO CD3/TAA BISPECIFIC ANTIBODIES

ANTI-LAG3 ANTIBODIES AND USES THEREOF

ANTIGEN-BINDING MOLECULES THAT BIND CD38 AND/OR CD28, AND USES THEREOF

INTERFERON RECEPTOR AGONISTS AND USES THEREOF

INTERFERON RECEPTOR AGONISTS AND USES THEREOF

MULTISPECIFIC ANTIGEN BINDING MOLECULES THAT BIND CD38 AND 4-1BB, A...

INTERLEUKIN-2 PROPROTEINS AND USES THEREOF

COMBINATION OF ANTIBODIES FOR TREATING CANCER WITH REDUCED CYTOKINE...

Bispecific Anti-PSMA x Anti-CD28 Antibodies and Uses Thereof

Bispecific Anti-MUC16 x Anti-CD28 Antibodies and Uses Thereof

Bispecific Anti-PSMA x Anti-CD28 Antibodies and Uses Thereof

Bispecific Anti-CD28 X Anti-CD22 Antibodies and Uses Thereof

IL12 RECEPTOR AGONISTS AND METHODS OF USE THEREOF

IL2-BASED THERAPEUTICS AND METHODS OF USE THEREOF

ANTIGEN-BINDING MOLECULES THAT BIND CD38 AND/OR CD28, AND USES THEREOF

BISPECIFIC ANTI-CD28 X ANTI-CD22 ANTIBODIES AND USES THEREOF

BISPECIFIC ANTI-MUC16 X ANTI-CD28 ANTIBODIES AND USES THEREOF

BISPECIFIC ANTI-PSMA X ANTI-CD28 ANTIBODIES AND USES THEREOF

ANTI-LAG3 ANTIBODIES AND USES THEREOF

Anti-LAG3 Antibodies and Uses Thereof